{"id":"W4400211491","doi":"10.1183/16000617.0015-2024","title":"Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis","year":2024,"lang":"en","type":"review","venue":"European Respiratory Review","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"Lung Foundation Netherlands; Servier; Horizon Therapeutics; Argenx; Galecto; Galderma; Eli Lilly and Company; AstraZeneca; CSL Behring; Sanofi; ZonMw; Amgen; Pfizer; Glenmark Pharmaceuticals; Acceleron; Daiichi-Sankyo; United Therapeutics Corporation","keywords":"Lysophosphatidic acid; Autotaxin; Medicine; Idiopathic pulmonary fibrosis; Fibrosis; Clinical trial; Inflammation; Disease; Receptor; Lung; Immunology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0008218169,0.001283946,0.003788969,0.0002824501,0.000218439,0.0001080629,0.0003040579,0.0002562194,0.001066945],"category_scores_gemma":[0.0001023644,0.0008987718,0.004635667,0.0006022396,0.0001374923,0.0001321479,0.0001968352,0.0005052874,0.005017655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006491972,"about_ca_system_score_gemma":0.0008870939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000137919,"about_ca_topic_score_gemma":6.428788e-8,"domain_scores_codex":[0.9947937,0.0007015154,0.001913375,0.001448834,0.000486374,0.0006562404],"domain_scores_gemma":[0.9973525,0.00004978004,0.0006102497,0.00119116,0.000205747,0.000590604],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001968311,0.0002624902,1.333695e-7,0.3206093,0.0005234131,0.001395229,0.000006350076,3.074603e-8,0.00002230693,0.00004382103,0.09075022,0.5861899],"study_design_scores_gemma":[0.0002617255,0.003427463,2.806926e-7,0.2784931,0.01140493,0.0002279605,0.000002387626,0.000001275575,0.000005620225,0.000005046978,0.705622,0.0005482242],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[6.982819e-7,0.9868781,0.00003503216,0.0002317403,0.001163208,0.005935078,0.002071119,0.0003165457,0.003368504],"genre_scores_gemma":[0.000003983192,0.9873424,0.0004451069,0.001666624,0.003729544,0.0008861779,0.002371023,0.0004820929,0.003073009],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6148718,"threshold_uncertainty_score":0.9999912,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05534831685234662,"score_gpt":0.3400771089941969,"score_spread":0.2847287921418503,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}